Patent · US Active

Inhibitors of hemeprotein-catalyzed lipid peroxidation

US8367669B2 · kind B2 · utility

0Cited by
20References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 26, 2008
Grant dateFeb 5, 2013
Priority date
Expiry dateSep 9, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compounds for the treatment or prevention of oxidative damage in a mammalian subject. The treatment and/or prevention may be on inhibiting heme-induced lipid peroxidation. Also discloses are methods and compounds for treating or preventing isoprostane-mediated tissue damage.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.